Zili Hu

10PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 31, 2026
CPNE1 promotes stemness and confers resistance to GPC3 CAR-T cell therapy in hepatocellular carcinoma via the STAT3-TGF-β signaling pathway.

|Aug 11, 2025
Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma.

Shuyue Liu, Yawen Xie, Tiantian Li

|Feb 04, 2025
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.

Yao-Jun Zhang, Jinbin Chen, Zhongguo Zhou

|Jan 21, 2025
Comparing PD-L1 and PD-1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single-center, real-world study.

Minrui He, Wa Xie, Ze Yuan

|May 13, 2024
Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion.

Yang Yu, Xiao-Hui Wang, Wen-Jie Hu

|Jul 27, 2023
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma.

Zhenyun Yang, Zili Hu, Yizhen Fu

Pageof 2

Frequent Collaborators

7 joint publications

Yizhen Fu

6 joint publications

Yaojun Zhang

4 joint publications

Yangxun Pan

3 joint publications

Jinbin Chen